Vivos Therapeutics, Inc. (VVOS) SEC Filings — 2025
20 SEC filings for Vivos Therapeutics, Inc. (VVOS) in 2025.
Filings
- Vivos Therapeutics Files 8-K: Other Events & Exhibits — 8-K · Dec 17, 2025
- Vivos Therapeutics Files 8-K on Definitive Agreement — 8-K · Dec 5, 2025
- Vivos Revenue Jumps 20% Amid Widening Losses, SCN Acquisition — 10-Q · Nov 19, 2025
- Vivos Therapeutics Files 8-K on Security Holder Vote Matters — 8-K · Nov 4, 2025
- Vivos Therapeutics Files 8-K — 8-K · Oct 24, 2025
- Vivos Seeks Shareholder Nod for Equity Plan Boost, Director Re-election — DEF 14A · Sep 29, 2025
- Vivos Therapeutics Updates Principal Office Address — 8-K · Sep 18, 2025
- Vivos Therapeutics Files 8-K — 8-K · Sep 12, 2025
- Vivos Therapeutics Files 8-K/A Amendment — 8-K/A · Aug 25, 2025
- Vivos Therapeutics Files 8-K on Financials — 8-K · Aug 20, 2025
- Vivos Therapeutics Files Q2 2025 10-Q — 10-Q · Aug 19, 2025
- Vivos Therapeutics Files 8-K: Agreements, Debt, and Equity Sales — 8-K · Jun 13, 2025
- Vivos Therapeutics Appoints New Auditor — 8-K · Jun 6, 2025
- Vivos Therapeutics Enters Material Agreement, Discloses Equity Sales — 8-K · May 23, 2025
- Vivos Therapeutics Files Q1 2025 10-Q — 10-Q · May 15, 2025
- Vivos Therapeutics Enters Material Definitive Agreement — 8-K · Apr 17, 2025
- Vivos Therapeutics Files 2024 10-K — 10-K · Mar 31, 2025
- Vivos Therapeutics Files 8-K: Agreements, Officer Changes, Financials — 8-K · Feb 14, 2025
- Vivos Therapeutics Files S-1/A Update — S-1/A · Jan 29, 2025
- Vivos Therapeutics Files S-1 for Potential Offering — S-1 · Jan 22, 2025